Founded in 2014, ARTPred B.V. is a research driven biotech company in the field of reproductive health. It is our vision to fundamentally improve fertility-care worldwide by making our technologies available to every IVF patient.
Together with our strategic alliances it is our objective to develop innovative solutions for implantation failure. A first step has been the development of our personalized predictive test for IVF outcome, named ReceptIVFity. As a second step we will focus on the development of therapeutic solutions for women with a “negative” microbiome profile, in order to improve pregnancy chance for those women.